A Retrospective Cohort Study Comparing Utilization and Costs of Biologic Therapies and JAK Inhibitor Therapy Across Four Common Inflammatory Indications in Adult US Managed Care Pa...

por Chastek, Benjamin, White, John, Van Voorhis, Damon, Tang, Derek, Stolshek, Bradley S.
Publicado 2016

Side Effects of Methotrexate and Tumor Necrosis Factor Inhibitors: Differences in Tolerability Among Patients With Psoriatic Arthritis and Rheumatoid Arthritis

por Ogdie, Alexis, Maksabedian Hernandez, Ervant J., Shaw, Yomei, Stolshek, Bradley, Michaud, Kaleb
Publicado 2022

Effectiveness and Costs Among Rheumatoid Arthritis Patients Treated with Targeted Immunomodulators Using Real-World U.S. Data

por Gharaibeh, Mahdi, Bonafede, Machaon, McMorrow, Donna, Hernandez, Ervant J. Maksabedian, Stolshek, Bradley S.
Publicado 2020

Perspectives on Treatment Burden for Methotrexate and Tumor Necrosis Factor Inhibitors Among Patients With Psoriatic Arthritis and Rheumatoid Arthritis: A Qualitative Study

por Ogdie, Alexis, Shaw, Yomei, Almonte, Michele, Maksabedian Hernandez, Ervant J., Stolshek, Bradley, Michaud, Kaleb
Publicado 2023

Days of Prophylactic Filgrastim Use to Reduce Febrile Neutropenia in Patients

por Scott, Shane J., Stolshek, Bradley S., Fridman, Moshe, Delgado, David J., Link, Brian K., Chrischilles, Elizabeth A.
Publicado 2003

Assessing the Association of Formulary Copayment Changes with Real-World Treatment Patterns in Patients with Rheumatoid Arthritis on Etanercept

por Bonafede, Machaon, Oko-osi, Hafiz, Gharaibeh, Mahdi, Manjelievskaia, Janna, Lopez-Gonzalez, Lorena, Collier, David H., Stolshek, Bradley S.
Publicado 2020

The Effect of Dose Escalation on the Cost-Effectiveness of Etanercept and Adalimumab with Methotrexate Among Patients with Moderate to Severe Rheumatoid Arthritis

por Incerti, Devin, Hernandez, Ervant J. Maksabedian, Tkacz, Joseph, Jansen, Jeroen P., Collier, David, Gharaibeh, Mahdi, Moore-Schiltz, Laura, Stolshek, Bradley S.
Publicado 2020

Decreased Injection Site Pain Associated with Phosphate-Free Etanercept Formulation in Rheumatoid Arthritis or Psoriatic Arthritis Patients: A Randomized Controlled Trial

por Cohen, Stanley, Samad, Ahmed, Karis, Elaine, Stolshek, Bradley S., Trivedi, Mona, Zhang, Hao, Aras, Girish A., Kricorian, Greg, Chung, James B.
Publicado 2019

Effects of Disease-Worsening Following Withdrawal of Etanercept or Methotrexate on Patient-Reported Outcomes in Patients With Rheumatoid Arthritis: Results From the SEAM-RA Trial

por Curtis, Jeffrey R., Stolshek, Bradley, Emery, Paul, Haraoui, Boulos, Karis, Elaine, Kricorian, Greg, Collier, David H., Yen, Priscilla K., Bykerk, Vivian P.
Publicado 2023

Patient-reported outcomes data in patients with psoriatic arthritis from a randomised trial of etanercept and methotrexate as monotherapy or in combination

por Strand, Vibeke, Mease, Philip J, Maksabedian Hernandez, Ervant J, Stolshek, Bradley S, Liu, Lyrica X H, Collier, David H, Kricorian, Gregory, Merola, Joseph F
Publicado 2021

Continuing Education

por Chrischilles, Elizabeth A., Cosler, Leon E., Delgado, David J., Fridman, Moshe, Link, Brian K., Mucenski, John W., Scott, Shane D., Semroc, Georgette N., Stolshek, Bradley S., Shogan, Jeffrey E., Tierce, Jonothan C.
Publicado 2003

Pharmacoeconomics and Considerations for Injectable Products: Focus on Colony-Stimulating Factors

por Chrischilles, Elizabeth A., Cosler, Leon E., Delgado, David J., Link, Brian K., Fridman, Moshe, Mucenski, John W., Scott, Shane D., Semroc, Georgette N., Shogan, Jeffrey E., Stolshek, Bradley S., Tierce, Jonothan C.
Publicado 2003

Feasibility and Utility of the Psoriasis Symptom Inventory (PSI) in Clinical Care Settings: A Study from the International Psoriasis Council

por Strober, Bruce, van de Kerkhof, Peter C. M., Callis Duffin, Kristina, Poulin, Yves, Warren, Richard B., de la Cruz, Claudia, van der Walt, Joelle M., Stolshek, Bradley S., Martin, Mona L., de Carvalho, Andre V. E.
Publicado 2019